Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The MABA approach: a new option to improve bronchodilator therapy.

× No keyword cloud information.

9 in total

Review 1. Umeclidinium/vilanterol: a review of its use as maintenance therapy in adults with chronic obstructive pulmonary disease.

Authors: Hannah A Blair; Emma D Deeks
Journal: Drugs Date: 2015-01 Impact factor: 9.546

2. Navafenterol (AZD8871) in patients with mild asthma: a randomised placebo-controlled phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending doses of this novel inhaled long-acting dual-pharmacology bronchodilator.

Authors: Eulalia Jimenez; Carol Astbury; Muna Albayaty; Ulrika Wählby-Hamrén; Beatriz Seoane; Cristina Villarroel; Helena Pujol; Maria Jesus Bermejo; Ajay Aggarwal; Ioannis Psallidas
Journal: Respir Res Date: 2020-09-09

3. Pharmacokinetics, Excretion, and Mass Balance of [¹⁴ C]-Batefenterol Following a Single Microtracer Intravenous Dose (Concomitant to an Inhaled Dose) or Oral Dose of Batefenterol in Healthy Men.

Authors: Claire Ambery; Graeme Young; Teresa Fuller; Aili L Lazaar; Adrian Pereira; Adam Hughes; David Ramsay; Frans van den Berg; Peter Daley-Yates
Journal: Clin Pharmacol Drug Dev Date: 2018-09-19

4. Randomized dose-finding study of batefenterol via dry powder inhaler in patients with COPD.

Authors: Courtney Crim; Michael L Watkins; Eric D Bateman; Gregory J Feldman; Isabelle Schenkenberger; Edward M Kerwin; Catriona Crawford; Krishna Pudi; Shuyen Ho; Charlotte Baidoo; Ramiro Castro-Santamaria
Journal: Int J Chron Obstruct Pulmon Dis Date: 2019-03-08

5. A randomized, controlled, repeat-dose study of batefenterol/fluticasone furoate compared with placebo in the treatment of COPD.

Authors: Courtney Crim; Mark Gotfried; Selwyn Spangenthal; Michael Watkins; Amanda Emmett; Catriona Crawford; Charlotte Baidoo; Ramiro Castro-Santamaria
Journal: BMC Pulm Med Date: 2020-05-04 Impact factor: 3.317

Review 6. Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease.

Authors: Josuel Ora; Angelo Coppola; Mario Cazzola; Luigino Calzetta; Paola Rogliani
Journal: J Exp Pharmacol Date: 2020-12-08

Review 7. The future of inhalation therapy in chronic obstructive pulmonary disease.

Authors: Mario Cazzola; Josuel Ora; Luigino Calzetta; Paola Rogliani; Maria Gabriella Matera
Journal: Curr Res Pharmacol Drug Discov Date: 2022-02-17

8. Population Pharmacokinetics and Pharmacodynamics of GSK961081 (Batefenterol), a Muscarinic Antagonist and β2-Agonist, in Moderate-to-Severe COPD Patients: Substudy of a Randomized Trial.

Authors: Claire L Ambery; Pascal Wielders; Andrea Ludwig-Sengpiel; Robert Chan; John H Riley
Journal: Drugs R D Date: 2015-09

9. In vitro anti-inflammatory effects of AZD8999, a novel bifunctional muscarinic acetylcholine receptor antagonist /β2-adrenoceptor agonist (MABA) compound in neutrophils from COPD patients.

Authors: Javier Milara; Sonia Contreras; Alfredo de Diego; Marta Calbet; Mònica Aparici; Esteban Morcillo; Montserrat Miralpeix; Julio Cortijo
Journal: PLoS One Date: 2019-01-04 Impact factor: 3.240